CG Oncology, Inc. - 10-Q Filing
CG Oncology reports third quarter 2026 results with 89.3 million shares outstanding as of November 4, 2026
Tickers: $CGON
Read the full article at SEC EDGAR
Part of the story Class Action Lawsuit Filed Against FuelCell Energy Following Financial Losses and Stock Decline (13 articles)